
September 24, 2026
Semaglutide has shown kidney benefits for people with type 2 diabetes and chronic kidney disease, while tirzepatide has shown promising effects on markers of kidney health. Both can also cause vomiting or diarrhea that leads to dehydration and acute kidney injury, so discuss persistent symptoms and kidney monitoring with your healthcare provider.





